RLYB earnings: a negative outcome, -10.6%

On March 15, 2022, Rallybio Corp reached its earnings. The result was a negative outcome, and the stock moved -10.6% in the window around the event. It had already run -28.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.